Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Denali Therapeutics Inc (DNLI)
Denali Therapeutics Inc (DNLI) Financials

DNLI Denali Therapeutics Inc

25.00

-0.16 (-0.64%)

29 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-56.313	-23.274	-6.379	-32.523	6.594	-19.318	-22.762	-11.111
Return on Equity (%)	157.853	-47.457	-7.237	-41.968	9.206	-27.506	-32.522	-14.008
Return on Invested Capital (%)	95.18	-76.519	-11.674	-57.274	8.434	-35.99	-43.856	-19.27
Operating Margin (%)	N/A	N/A	-28.368	-742.053	21.438	-598.335	-300.536	-43.927
Net Profit Margin (%)	N/A	N/A	-28.368	-740.738	21.193	-597.154	-300.555	-43.937
Book Value Per Share	-10.952	5.325	5.777	4.105	9.546	7.869	7.667	7.46
Earnings Per Share	-10.079	-1.008	-0.387	-2.054	0.59	-2.376	-2.398	-1.051
Cash Per Share	4.636	2.496	0.815	0.826	4.208	2.4	1.604	0.92
Working Capital Per Share	20.106	4.52	4.733	3.999	11.814	4.244	7.417	7.136
Operating Profit Per Share	N/A	N/A	1.364	0.277	2.785	0.398	0.798	2.392
EBIT Per Share	-10.079	-1.008	-0.387	-2.058	0.597	-2.381	-2.397	-1.051
EBITDA Per Share	-10.079	-1.008	-0.387	-2.058	0.597	-2.381	-2.397	-1.051
Free Cash Flow Per Share	-9.54	-1.01	-0.43	-1.951	0.545	-2.377	-2.343	-1.078

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	8.6M	87.48M	94.66M	96.19M	120.53M	122.28M	135.97M	N/A

Key Stats and Ratios

Year End 31 December 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	122.86M	123.16M	N/A	135.97M	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	-154.766	N/A	N/A	N/A	-312.401	N/A	N/A	N/A
Net Profit Margin (%)	-154.766	N/A	N/A	N/A	-312.401	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	3.62B
Price to Earnings Ratio	-24.78
Price to Sales Ratio	10.89
Price to Cash Ratio	28.31
Price to Book Ratio	3.49
Dividend Yield	-

Share Statistics

Shares Outstanding	143.92M
Average Volume (1 week)	1.11M
Average Volume (1 Month)	976.92k
52 Week Change	35.50%
52 Week High	33.33
52 Week Low	14.56

More Ratios Coming Soon!

Denali Therapeutics

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions